Articles
Page 24 of 28
-
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P78
-
The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P75 -
Endothelial GC-A can be a therapeutic target for metabolic syndrome
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P73 -
Receptor guanylyl cyclase B-mediated cGMP signalling controls axon bifurcation of cranial sensory ganglion neurons at the embryonic hindbrain
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P71 -
Differential regulation of platelet inhibition by cGMP- and cAMP-dependent protein kinases
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P69 -
Krait natriuretic peptide (KNP): a non-classical NP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P67 -
Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P65 -
Function of cGMP-dependent protein kinase II in volume expansion-induced diuresis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P63 -
Suppression of kidney fibrosis by cGMP-dependent protein kinase I
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P61 -
In striatum phosphodiesterase 10A is part of a synaptic signalling complex
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P59 -
Soluble guanylyl cyclase mediates concomitant coronary vasodilator and positive inotropic actions of the HNO donor Angeli's salt in the intact rat heart
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P57 -
Platelet inhibitory effects of the NO independent sGC stimulator riociguat (Bay 63-2561)
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P55 -
Protective role of endogenous cardiac natriuretic peptide/GC-A system on the maternal heart during the postpartum period
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P53 -
ANP/GC-A signaling attenuates tissue injury by cisplatin
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P51 -
The effects of super-flux (high performance) dialyzer on the plasma glycosylated pro-B-type natriuretic peptide (proBNP) and glycosylated N-terminal proBNP in end-stage renal disease patients on dialysis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P47 -
Endothelial dysfunction in adipose triglyceride lipase deficiency: role of perivascular adipose tissue
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P45 -
M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P43 -
Transforming PKA into PKG – a structure-function approach to understand cyclic nucleotide selectivity
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P41 -
Evidence for functional coupling of cGMP/cGKI signalling and TRPC channels in endothelium but not in vascular smooth muscle
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P40 -
Metabolic fate of orally administered cGMP in rats
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P39 -
Differential effects of PDE5 inhibitors on cardiac dysfunction in the MDX ouse model of Duchenne muscular dystrophy
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O38 -
A biodegradable in-situ polymer precipitation delivery system for sustained delivery of a novel chimeric natriuretic peptide CD-NP in an experimental model of myocardial infarction
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P38 -
Nitric oxide regulated cyclic di-GMP signaling
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O37 -
Increases survival by apo-sGC activation via post-stroke blood brain barrier stabilisation and anti-inflammation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P36 -
A novel physiological significance of natriuretic peptides in cancer metastasis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O34 -
67-kDa laminin receptor and cGMP induced cancer-selective apoptosis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O33 -
NO-H2S interactions involve cGMP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O32 -
Phosphodiesterase 5 is main regulator of brown adipocyte differentiation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P32 -
Cell type-specific knock out models to unravel NO/cGMP signaling in smooth muscle
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O29 -
GUCY2C at the intersection of obesity and colorectal cancer
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O28 -
The role of VASP in cGMP-mediated vascular smooth muscle relaxation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P28 -
PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P26 -
Natriuretic peptides and fat metabolism
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O24 -
Guanylyl cyclase-B plays an important role in adipogenesis and “browning” of white fat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P24 -
Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P23 -
Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P21 -
New mechanisms of normoxic and hypoxic cGMP signalling mediated by the nitrite anion
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O20 -
The soluble guanylyl cyclase stimulator BAY 41-2272 increases differentiation and function of brown adipocytes
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P20 -
Mechanisms driving heme insertion into apo-sGC during its maturation in cells
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O18 -
A tissue based chemical proteomics screen to identify novel G-kinase associated proteins (GKAPs)
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P16 -
Conformational changes involved in sGC activation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O12 -
G-protein signaling modulator 1 is a modifier of sGC-dependent vascular response
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P11 -
Identification of protein kinase G I alpha interacting proteins as potential targets to prevent cardiac remodeling
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P10 -
Pulmonary vascular adaptation to high-altitude living
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O9 -
Role of NO-sensitive guanylyl cyclase in angiogenesis and arteriogenesis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P8 -
What have genome-wide association studies taught us about cGMP and blood pressure regulation?
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O5 -
Abstract not submitted for publication
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O3 -
Increased nitrosative/oxidative stress lowers myocardial protein kinase G activity in heart failure with preserved ejection fraction
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O2 -
Neutral endopeptidase inhibitors SOL-1 and candoxatril counteract kidney fibrosis by reducing myofibroblast formation in mouse UUO model
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P1 -
Chronic natriuretic peptide protein therapeutics
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):O1
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 2.8
5-year Journal Impact Factor: 2.7
Source Normalized Impact per Paper (SNIP): 0.774
SCImago Journal Rank (SJR): 0.710
Speed 2024
Submission to first editorial decision (median days): 15
Submission to acceptance (median days): 130
Usage 2024
Downloads: 786,626
Altmetric mentions: 260
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication